ThomasVincentJohnsonMD

PubMed

• 3 citations
  ACR Appropriateness Criteria® Asymptomatic Patient at Risk for Coronary Artery Disease: 2021 Update.
  Brian B. Ghoshhajra, Sandeep Hedgire, Lynne M. Hurwitz Koweek, Garth M. Beache, Richard K J Brown, Andrew M. Davis, Joe Y. Hsu, Thomas V Johnson, Gregory Kicska, Seth ...> ;Journal of the American College of Radiology. 2021 May 1
• 1 citations
  Impact of COVID-19 on Work-Related Musculoskeletal Disorders for Cardiac Sonographers.
  Jill Mazal, Noreen Kelly, Thomas V. Johnson, Geoffrey A. Rose, Dermot Phelan> ;Journal of the American Society of Echocardiography. 2021 Jan 7
• Correctly Estimating Systolic Anterior Motion Risk: Seeking Guidance from the Guidelines
  Thomas V. Johnson, Dermot Phelan, Andrew Kott, Noreen Kelly> ;Journal of the American Society of Echocardiography. 2021 Jan 1
• 1 citations
  Laboratory Accreditation: Why This Quality Matter Matters
  Geoffrey A. Rose, Thomas V. Johnson> ;Journal of the American Society of Echocardiography. 2017 Sep 1
• Time-Lapse Retinal Ganglion Cell Dendritic Field Degeneration Imaged in Organotypic Retinal Explant Culture.
  Johnson TV, Oglesby EN, Steinhart MR, Cone-Kimball E, Jefferys J, Quigley HA> ;Invest. Ophthalmol. Vis. Sci.. 2016-01-01
• 21 citations
  Improving appropriate use of echocardiography and single-photon emission computed tomographic myocardial perfusion imaging: a continuous quality improvement initiative.
  Thomas V. Johnson, Geoffrey A. Rose, Deborah J. Fenner, Nigel Rozario> ;Journal of the American Society of Echocardiography. 2014 Jul 1
• 26 citations
  Improvement in the Assessment of Diastolic Function in a Clinical Echocardiography Laboratory Following Implementation of a Quality Improvement Initiative
  Thomas V. Johnson, John D. Symanski, Sanjay R. Patel, Geoffrey A. Rose> ;Journal of the American Society of Echocardiography. 2011 Nov 1
• Broadening our focus in the search for cell transplantation-based glaucoma therapies.
  Johnson, T. V., Martin, K. R.> ;Eye (Lond). 2011 May
• Stem cell therapy for glaucoma: possibilities and practicalities.
  Johnson, T.V., Bull, N.D., Martin, K.R.> ;Expert Rev Ophthalmol. 2011 Apr 1
• Use of an adult retinal explant model for screening of potential retinal ganglion cell neuroprotective therapies.
  Bull, N.D., Johnson, T.V., Welsapar, G., DeKorver, N.W., Tomarev, S.I., Martin, K.R.> ;Invest Ophthalmol Vis Sci. 2011 May
• Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use.
  Johnson, T.V., Gupta, P.K., Vudathala, D.K., Blair, I.A., Tanna, A.P.> ;J Ocul Pharmacol Ther. 2011 Feb
• Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treat...
  Johnson, T.V., Fan, S., Zhan, G., Camras, C.B., Toris, C.B.> ;J Glaucoma. 2010 Aug
• Neurotrophic factor delivery as a protective treatment for glaucoma.
  > ;Exp Eye Res. 2011 Aug
• Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.
  Johnson, T.V., Bull, N.D., Hunt, D.P., Marina, N., Tomarev, S.I., Martin, K.R.> ;Invest Ophthalmol Vis Sci. 2010-04-01
• Rodent models of glaucoma.
  Johnson, T.V., Tomarev, S.I.> ;Brain Res Bull. 2010-02-15
• Identification of barriers to retinal engraftment of transplanted stem cells.
  Johnson, T.V., Bull, N.D., Martin, K.R.> ;Invest Ophthalmol Vis Sci. 2010-02-01
• Transplantation prospects for the inner retina.
  Johnson, T. V., Bull, N. D., Martin, K. R.> ;Eye (Lond). 2009 Oct 01
• Stem cells for neuroprotection in glaucoma.
  Bull, N. D., Johnson, T. V., Martin, K. R.> ;Prog Brain Res. 2008 Oct 22
• Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model.
  Johnson, T.V., Martin, K.R.> ;Invest Ophthalmol Vis Sci. 2008 Aug
• Aqueous humor dynamics in exfoliation syndrome.
  Johnson, T.V., Fan, S., Camras, C.B., Toris, C.B.> ;Arch Ophthalmol. 2008 Jul
• Toll-like receptors: roles in neuroprotection?
  Hanisch, U. K., Johnson, T. V., Kipnis, J.> ;Trends Neurosci. 2008 Apr
• Rebound tonometry in conscious, conditioned mice avoids the acute and profound effects of anesthesia on intraocular pressure.
  Johnson, T.V., Fan, S., Toris, C.B.> ;J Ocul Pharmacol Ther. 2008 Apr
• Effects of central corneal thickness on the efficacy of topical ocular hypotensive medications.
  Johnson, T.V., Toris, C.B., Fan, S., Camras, C.B.> ;J Glaucoma. 2008 Mar
• T cell independent mechanism for copolymer-1-induced neuroprotection.
  Liu, J., Johnson, T. V., Lin, J., Ramirez, S. H., Bronich, T. K., Caplan, S., Persidsky, Y., Gendelman, H. E., Kipnis, J.> ;Eur J Immunol. 2007 Nov
• Bacterial DNA confers neuroprotection after optic nerve injury by suppressing CD4+CD25+ regulatory T-cell activity.
  Johnson, T.V., Camras, C.B., Kipnis, J.> ;Invest Ophthalmol Vis Sci. 2007 Aug
• Join now to see all